1. Stocks
  2. Integra Lifesciences Holdings Corp
  3. Swot
swot-logo

Integra Lifesciences Holdings Corp SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Integra Lifesciences Holdings Corp has 11 Strengths, 16 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

Rising Momentum: Momentum Score Weekly Gainers

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over the Quarter (3 Months)

Turnaround Companies: Loss to Profit QoQ

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Increasing profits every quarter for the past 2 quarters

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

Momentum Trap (DVM)

Await Turnaround (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Top Losers

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Book Value Per Share deteriorating for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Top Losers

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks